|About||Portfolio||Programs||News||Learning Center||Member Center|
Springboard's 19th Venture Forum Program
About AllThingsLifeSciences: 2009
AllThingsLifeSciences: 2009, Springboard's 19th venture forum, showcased 30 investment-ready high growth life science opportunities led by women. Taking presenting companies to hotspots of life science activity on both coasts and in the heart of the country, the program brought this year's class of presenters to investors, business development executives, and other strategic partners in Madison, WI, Silicon Valley, and New York City. The Bootcamp program gave them exposure in our Nation's capital for a two day intensive program which included a briefing at the White House and a reception with members of Congress on Capitol Hill.
Click here to learn more about our venture forums.
What people are saying...
Click here to see more testimonials.
Washington DC Bootcamp
When: July 15-16, 2009
In a trio of events in Washington, DC Springboard welcomed the newest class of women-led life science companies at a two day intensive program which included a briefing at the White House and a Reception with Congressman Van Hollen (MD-8), Congresswoman Jackie Speier (CA-12) and other members of Congress on Capitol Hill. The program left attendees and presenters lauding it as energizing, inspirational, and life-changing.
To read about Springboard's White House Briefing on the White House's official blog, click here.
"A life-changing experience in all respects! I hope there is a congressional medal of honor at some point, because that's what everyone at Springboard deserves."
Susan Catalano, Cognition Therapeutics (ATLS 09)
- hosted by the Office of Public Engagement
Speakers: Elizabeth Vale, Business Liaison, Office of Public Engagement
Tom Kalil, Deputy Director of the White House Office of Science and Technology
Dr. Kavita Patel, Director of Policy for the Office of Public Engagement and Intergovernmental Affairs
Heather Zichal, Deputy Assistant to the President for Energy and Climate Change
Dr. Pamela Reilly Contag, CEO ConcentRx
Kay Koplovitz, Chairman, Springboard Enterprises
- CAPITOL HILL RECEPTION
co-hosted by Women In Bio
Congresswoman Jackie Speier (CA-12)
Congresswoman Debbie Wasserman Schultz (FL-20)
Congressman Chris Van Hollen (MD-8)
Jim Greenwood, CEO, BIO
Jill Griffiths, VP Global Thought Leadership, Aetna
Kay Koplovitz, Chair, Springboard Enterprises
Madison Venture Forum
When: October 1, 2009
Where:University of Wisconsin, Fluno Center
601 University Avenue, Madison, WI 53715
With the support of the Phenomenelle Angels, several State Government Departments and the University of Wisconsin, Madison Dean of the College of Letters and Science, the Madison venture forum was the first stop in the ATLS road show. The forum, plus an Equity Matters Seminar program and pre-forum reception the evening before, was held at the Fluno Center at the University of Wisconsin in Madison on October 1, 2009 to an audience of Midwest angel investors, venture capitalists and area service providers. An expert panel of entrepreneurs launched the day’s 18 company presentations, divided by timely “break-out” sessions in the demo area designed for one-on-one discussions and by a “Meet the Companies” luncheon that further facilitated the connections between potential funders and our presenting companies. Lieutenant Governor Barbara Lawton gave an inspiring speech about the developing Madison bioscience sphere and the importance of Springboard’s involvement. Secretary of Financial Institutions Lauri Keating Heinemann participated and the day concluded with a panel of Midwest investors.
"Springboard has been one of the best experiences of my life."
Deborah Mash, Ibogen, Inc. (ATLS 09)
Silicon Valley Venture Forum
When: October 15, 2009
Where:Paul Brest Hall, Building 4
Munger Complex, Stanford University
559 Nathan Abbott Way, Stanford, CA 94305
The Silicon Valley venture forum on October 15, 2009 was hosted in partnership with Silicon Valley-based Life Science Angels. Springboard Chairman Kay Koplovitz, President Amy Millman and a panel of Springboard Alumnae met with 20 women professors and researchers from the Stanford Medical School for a special pre-forum meeting and an al fresco reception was held the night before for about 100 supporters and alumnae hosted by Springboard Advisory Council member Ellen Hancock at her Los Altos home. The next day 19 companies presented at the Stanford Law School facility to an intimate group of angels, venture capitalists, program sponsors, coaches, and officials from the University.
"Thank you again for a wonderful event – the fruit of your efforts over the last few months were obvious – the [women] were outstanding and gave wonderful pitches."
Yael Weiss, Merck & Co., Inc.
New York City Venture Forum
When: October 30, 2009
Where:Pricewaterhouse Coopers LLP
300 Madison Avenue, New York, NY 10017
Working with the New York City Investment Fund and the New York Biotechnology Association in a high-profile partnership, the New York City venture forum took place at PricewaterhouseCoopers in front of a diverse group of investors, business development executives, University tech transfer agents, sponsors, coaches and experts from the New York life sciences scene. Keynote speaker Dr. Peter Corr of Celtic Therapeutics and former head of science and technology for Pfizer, discussed how start-up life science companies can help address the current discovery and development challenges faced by large pharmaceutical companies. Featured speakers New York City Economic Development Corporation’s President Seth Pinsky, New York City Investment Fund’s President & CEO Maria Gotsch and New York Biotechnology Association President Nathan Tinker all underscored the opportunities the city has to offer life sciences companies with emphasis on the 2010 opening of the new East River Science Park, managed by sponsor Alexandria Real Estate. Twenty-four companies presented in NYC – from biotechnology and devices to diagnostics, healthcare and health IT.
"Thank you a million times! Words cannot express what a great experience this has been! I am grateful to all of you for your help, guidance and patience! I am proud to be a Springboard alumna and look forward to the future with all of you!"
Michelle White, Michelle's Miracle (ATLS 09)
Venture-catalyst Springboard Enterprises is the go-to organization for information about and support for entrepreneurial ventures led by women. Springboard sources, qualifies, coaches, and showcases igh growth potential companies seeking equity capital for product development and expansion. The 400+ women-led companies that have presented at Springboard forums have raised over $4.5 billion in equity, grants and corporate investments to date.
Madison Forum Co-Host:
Phenomenelle Angels Fund I, LP is an early stage fund that invests in women and minority owned or managed businesses in Wisconsin and the Midwest. Qualifying businesses must have at least one woman or an ethnic minority holding substantial ownership or in an executive (C-level) position. Investors are limited to women who are accredited investors, and select entities. They invest in exceptional management teams that exploit proprietary technology to create breakthrough applications in the following market sectors: Information Technology, BioTechnology/Life Sciences, Clean Technology, Consumer Goods/Services and Communications. The Phenomenelle Angels Fund fills special unmet investment opportunities in women and minority owned and/or managed businesses. They leverage our investor base of successful women entrepreneurs as well as our experienced Business Advisory Board, Technical Advisory Board and Investment Committee to assist portfolio companies with recruiting, sales and marketing, strategic partnerships, board development, operations, finance and access to additional debt and equity capital.
Silicon Valley Forum Co-Host:
Life Science Angels is a not-for-profit corporation that takes no carry or management fees on any investment. We hold membership meetings approximately every other month, with one or two companies presenting. Any opportunity presented to the membership for investment has passed a rigorous due diligence process led by either our biotechnology or medical device investment committee. Each committee is comprised of approximately 12 LSA members with significant business and scientific expertise. If selected, there is no charge to the companies to present. Members make their own individual investment decisions and are afforded an opportunity for additional due diligence if they wish. The investments are made through an LLC so the funded companies see a single investor. LSA typically takes a seat on the company’s board. Direct investments range from $250k to $750k and syndicated financings may range from $1.5 million to $6 million.
New York City Forum Co-Hosts:
The New York Biotechnology Association is a not-for-profit trade association dedicated to the development and growth of New York State based biotechnology related industries and institutions, and to strengthening the competitiveness of New York State as a premier global location for biotechnology/biomedical research, education and industry. Through their membership of 250 bioscience companies, world class research institutes and related professional services; biotechnology professionals are able to access the information, resources and assistance they need to make their ventures a success.
The New York City Investment Fund is a private fund with a civic mission. The fund was the vision of Henry R. Kravis, founding partner of Kohlberg Kravis Roberts & Co., who serves as its Founding Chairman. His goal was to mobilize the city's financial and business leaders to help build a stronger and more diversified local economy. To that end, the Fund has built a network of top experts from the investment and corporate communities who help identify and support New York City's most promising entrepreneurs in both the for-profit and not-for-profit sectors. The Fund has raised in excess of $110 million. Its investments typically range in size from $1 million to $5 million. The Fund provides equity or debt, structured to meet the needs of the project. It will invest at any stage of business development, but is seeking to exit in about five years. To date, the Fund has invested in over eighty projects.